Impact of protein-glycan interactions in the regulation of autoimmunity and chronic inflammation

被引:24
作者
Bianco, German A. [1 ]
Toscano, Marta A. [1 ]
Ilarregui, Juan M. [1 ]
Rabinovich, Gabriel A. [1 ]
机构
[1] Univ Buenos Aires, Fac Med, Hosp Clin Jose San Martin, Div Immunogenet, RA-1120 Buenos Aires, DF, Argentina
关键词
apoptosis; autoimmunity; galectins; galectin-1; glycosylation; immunoregulation;
D O I
10.1016/j.autrev.2006.02.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protein-glycan interactions control essential immunological processes, including T-cell activation, differentiation and survival. Galectins, carbohydrate-binding proteins, defined by shared consensus amino acid sequences and affinity for beta-galactose-containing oligosaccharides, participate in a wide spectrum of immunological processes. These carbohydrate-binding proteins regulate the development of pathogenic T-cell responses by influencing T-cell survival, activation and cytokine secretion. Administration of recombinant galectins or their genetic delivery modulate the development and severity of chronic inflammatory responses in experimental models of autoimmunity by triggering different and potentially overlapping immunoregulatory mechanisms. Given the potential use of galectins as novel anti-inflammatory agents or targets for immunosuppressive drugs, we will summarize here recent findings on the influence of these carbohydrate-binding proteins in autoimmune and chronic inflammatory disorders. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 41 条
[1]   The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death [J].
Amano, M ;
Galvan, M ;
He, JL ;
Baum, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7469-7475
[2]   Amelioration of graft versus host disease by galectin-1 [J].
Baum, LG ;
Blackall, DP ;
Arias-Magallano, S ;
Nanigian, D ;
Uh, SY ;
Browne, JM ;
Hoffmann, D ;
Emmanouilides, CE ;
Territo, MC ;
Baldwin, GC .
CLINICAL IMMUNOLOGY, 2003, 109 (03) :295-307
[3]  
Blaser C, 1998, EUR J IMMUNOL, V28, P2311, DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO
[4]  
2-G
[5]   Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction [J].
Chung, CD ;
Patel, VP ;
Moran, M ;
Lewis, LA ;
Miceli, MC .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3722-3729
[6]   Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation [J].
Demetriou, M ;
Granovsky, M ;
Quaggin, S ;
Dennis, JW .
NATURE, 2001, 409 (6821) :733-739
[7]   Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell lines [J].
Fajka-Boja, R ;
Szemes, M ;
Ion, G ;
Légrádi, A ;
Caron, M ;
Monostori, É .
IMMUNOLOGY LETTERS, 2002, 82 (1-2) :149-154
[8]  
Fukumori T, 2003, CANCER RES, V63, P8302
[9]   Preface - Animal lectins and life: a guided tour into the realm of the sugar code [J].
Gabius, HJ .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1572 (2-3) :163-164
[10]   Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1 [J].
Galvan, M ;
Tsuboi, S ;
Fukuda, M ;
Baum, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (22) :16730-16737